# The Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia

> **NCT02858843** · NA · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 1 (actual)

## Conditions studied

- Cystic Fibrosis
- Diabetes

## Interventions

- **DRUG:** lumacaftor-ivacaftor

## Key facts

- **NCT ID:** NCT02858843
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08-01
- **Primary completion:** 2018-05-01
- **Final completion:** 2018-05-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** We were unable to enroll eligible subjects for the study.
- **Last updated:** 2018-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02858843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02858843, "The Effect of Combination Lumacaftor and Ivacaftor on Markers of Hyperglycemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02858843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*